OpenURL Connection Search

Select item for more details and to access through your institution.

Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study.
Published in:
Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 4, p. 975, doi. 10.1007/s00432-021-03693-5
By:
- Leclerc, V.;
- Karlin, L.;
- Herledan, C.;
- Marchal, L.;
- Baudouin, A.;
- Gouraud, A.;
- Caffin, A. G.;
- Larbre, V.;
- Lazareth, A.;
- Bachy, E.;
- Salles, G.;
- Ghesquières, H.;
- Rioufol, C.;
- Ranchon, F.
Publication type:
Article
Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA.
Published in:
British Journal of Haematology, 2023, v. 202, n. 2, p. 379, doi. 10.1111/bjh.18859
By:
- Marouf, A.;
- Molinari, N.;
- Sibon, D.;
- Cottereau, A. S.;
- Kanoun, S.;
- Antoine, C.;
- Debureaux, P. E.;
- Cavalieri, D.;
- Fornecker, L. M.;
- Casasnovas, R. O.;
- Herbaux, C.;
- Amorim, S.;
- Rossi, C.;
- Bouscary, D.;
- Brice, P.;
- Ghesquieres, H.;
- Tamburini, J.;
- Deau, B.
Publication type:
Article
Adrenal lymphoma: presentation, management and prognosis.
Published in:
QJM: An International Journal of Medicine, 2017, v. 110, n. 2, p. 103, doi. 10.1093/qjmed/hcw174
By:
- Laurent, C.;
- Casasnovas, O.;
- Martin, L.;
- Chauchet, A.;
- Ghesquieres, H.;
- Aussedat, G.;
- Fornecker, L. M.;
- Bologna, S.;
- Borot, S.;
- Laurent, K.;
- Bouillet, B.;
- Verges, B.;
- Petit, J.-M.
Publication type:
Article
Sarcoidosis and lymphoma: a comparative study.
Published in:
QJM: An International Journal of Medicine, 2015, v. 108, n. 11, p. 871, doi. 10.1093/qjmed/hcv039
By:
- CHALAYER, É.;
- BACHY, E.;
- OCCELLI, P.;
- WEILER, L.;
- FAURIE, P.;
- GHESQUIERES, H.;
- PAVIC, M.;
- BROUSSOLLE, C.;
- SÈVE, P.
Publication type:
Article
P14.54 Primary central nervous system lymphoma of the spinal cord: a LOC network cohort study.
Published in:
2021
By:
- Valyraki, N;
- Ahle, G;
- Tabouret, E;
- Houot, R;
- Jardin, F;
- Ghesquieres, H;
- Choquet, S;
- Moles, M;
- Hoang-Xuan, K;
- Houillier, C
Publication type:
Case Study
P14.45 Primary diffuse large B-cell CNS lymphoma over 80 years: an analysis of 110 patients from the french Oculo-Cerebral Lymphoma (LOC) network.
Published in:
Neuro-Oncology, 2019, v. 21, p. iii77, doi. 10.1093/neuonc/noz126.280
By:
- MAAREK, A;
- Maucort-Boulch, D;
- Houillier, C;
- Hoang-Xuan, K;
- Soussain, C;
- Ghesquières, H
Publication type:
Article
Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.
Published in:
2008
By:
- Sebban C;
- Dussart S;
- Fuhrmann C;
- Ghesquieres H;
- Rodrigues I;
- Geoffrois L;
- Devaux Y;
- Lancry L;
- Chvetzoff G;
- Bachelot T;
- Chelghoum M;
- Biron P;
- Sebban, Catherine;
- Dussart, Sophie;
- Fuhrmann, Christine;
- Ghesquieres, Hervé;
- Rodrigues, Isabelle;
- Geoffrois, Lionel;
- Devaux, Yves;
- Lancry, Laurence
Publication type:
journal article
A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.
Published in:
Nature Communications, 2014, v. 5, n. 6, p. 3856, doi. 10.1038/ncomms4856
By:
- Cozen, W.;
- Timofeeva, M. N.;
- Li, D.;
- Diepstra, A.;
- Hazelett, D.;
- Delahaye-Sourdeix, M.;
- Edlund, C. K.;
- Franke, L.;
- Rostgaard, K.;
- Van Den Berg, D. J.;
- Cortessis, V. K.;
- Smedby, K. E.;
- Glaser, S. L.;
- Westra, H.-J.;
- Robison, L. L.;
- Mack, T. M.;
- Ghesquieres, H.;
- Hwang, A. E.;
- Nieters, A.;
- de Sanjose, S.
Publication type:
Article
Phase II trial and prediction of response of single agent tipifarnib in patients with relapsed/refractory mantle cell lymphoma: a Groupe d'Etude des Lymphomes de l'Adulte trial.
Published in:
2010
By:
- Rolland D;
- Ribrag V;
- Haioun C;
- Ghesquieres H;
- Jardin F;
- Bouabdallah R;
- Franchi P;
- Briere J;
- De Kerviler E;
- Chassagne-Clement C;
- Raponi M;
- Houlgatte R;
- Jais JP;
- Thieblemont C;
- Rolland, Delphine;
- Ribrag, Vincent;
- Haioun, Corinne;
- Ghesquieres, Herve;
- Jardin, Fabrice;
- Bouabdallah, Reda
Publication type:
journal article
TRANSCEND FL: PHASE 2 STUDY RESULTS OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL).
Published in:
Hematological Oncology, 2023, v. 41, p. 877, doi. 10.1002/hon.3196_LBA4
By:
- Morschhauser, F.;
- Dahiya, S.;
- Palomba, M. L.;
- Garcia‐Sancho, A. M.;
- Ortega, J. L. Reguera;
- Kuruvilla, J.;
- Jager, U.;
- Cartron, G.;
- Izutsu, K.;
- Dreyling, M.;
- Kahl, B.;
- Ghesquieres, H.;
- Ardeshna, K.;
- Goto, H.;
- Barbui, A. M.;
- Abramson, J. S.;
- Borchmann, P.;
- Fleury, I.;
- Mielke, S.;
- Farazi, T.
Publication type:
Article
COMBINING CD19‐4‐1BBL (RO7227166) WITH GLOFITAMAB IS SAFE AND SHOWS EARLY EFFICACY IN PATIENTS SUFFERING FROM RELAPSED OR REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2023, v. 41, p. 136, doi. 10.1002/hon.3163_91
By:
- Hutchings, M.;
- Dickinson, M.;
- Carlo‐Stella, C.;
- Morschhauser, F.;
- Bosch, F.;
- Gritti, G.;
- Townsend, W.;
- Bartlett, N. L.;
- Cartron, G.;
- Ghesquieres, H.;
- Houot, R.;
- Walter, H.;
- Offner, F.;
- Christiansen, A.;
- Dimier, N.;
- Jamois, C.;
- Harrop, E.;
- Herter, S.;
- Hölzlwimmer, G.;
- Keelara, A.
Publication type:
Article
Comparison of overall survival of lisocabtagene maraleucel (liso‐cel) versus standard of care (SOC) adjusting for crossover in second‐line (2L) R/R large B‐cell lymphoma.
Published in:
Hematological Oncology, 2023, v. 41, p. 451, doi. 10.1002/hon.3164_332
By:
- Morschhauser, F.;
- Ghesquieres, H.;
- Kamdar, M.;
- Liu, F. F.;
- Chandler, C.;
- Crotta, A.;
- Klijn, S. L.;
- Elsada, A.;
- Previtali, A.;
- Chaillol, I.;
- Proskorovsky, I.;
- Schmitz, N.;
- Gisselbrecht, C.;
- Abramson, J. S.
Publication type:
Article
Autologous hematopoietic cell transplantation (autoHCT) for T‐cell/histiocyte‐rich large B‐cell lymphoma (THRLBCL): An EBMT Lymphoma Working Party study.
Published in:
Hematological Oncology, 2023, v. 41, p. 447, doi. 10.1002/hon.3164_329
By:
- Renders, S.;
- Finel, H.;
- Ngoya, M.;
- Boumendil, A.;
- Schaap, N.;
- Ghesquieres, H.;
- Bloor, A.;
- Pérez‐Simón, J. A.;
- Huynh, A.;
- Kobbe, G.;
- Collin, M.;
- Busca, A.;
- Helbig, G.;
- Aljurf, M.;
- Daskalakis, M.;
- Schroers, R.;
- Carpenter, B.;
- Rubio, M. T.;
- Peniket, A.;
- Sureda, A.
Publication type:
Article
Combination of pixantrone with rituximab, ifosfamide and etoposide in relapsed/refractory aggressive non‐Hodgkin lymphoma. Results from a phase II LYSA study (PIVeR).
Published in:
Hematological Oncology, 2023, v. 41, p. 437, doi. 10.1002/hon.3164_322
By:
- Fornecker, L.;
- Delwail, V.;
- Thieblemont, C.;
- Ghesquieres, H.;
- Bouabdallah, K.;
- Tilly, H.;
- Le Calloch, R.;
- Morschhauser, F.;
- Costello, R.;
- Slama, B.;
- Gyan, E.;
- Chauchet, A.;
- Ngirabacu, M.;
- Durot, E.;
- Choquet, S.;
- Capdupuy, C.;
- Le Goff, M.;
- Voillat, L.;
- Snauwaert, S.;
- Amorim, S.
Publication type:
Article
Distinct molecular determinants of treatment‐failure in elderly Hodgkin lymphoma identified by cell‐free DNA profiling: A LYSA Study.
Published in:
Hematological Oncology, 2023, v. 41, p. 321, doi. 10.1002/hon.3164_228
By:
- Rossi, C.;
- Boegeholz, J. L.;
- Alig, S. K.;
- Garofolo, A.;
- Esfahani, M. Shahrokh;
- Schroers‐Martin, J.;
- Olsen, M.;
- Kang, X.;
- Kurtz, D. M.;
- Sugio, T.;
- Hamilton, M. P.;
- André, M.;
- Casasnovas, O.;
- Diehn, M.;
- Ghesquières, H.;
- Alizadeh, A. A.
Publication type:
Article
LISOCABTAGENE MARALEUCEL (LISO‐CEL) VERSUS STANDARD OF CARE (SOC) AS SECOND‐LINE THERAPY IN LARGE B‐CELL LYMPHOMA (TRANSFORM STUDY): SUBGROUP ANALYSES BY PRIOR THERAPY RESPONSE.
Published in:
Hematological Oncology, 2023, v. 41, p. 212, doi. 10.1002/hon.3163_138
By:
- Nastoupil, L. J.;
- Kamdar, M.;
- Chavez, J. C.;
- Ghesquieres, H.;
- Ghosh, M.;
- Holmes, H.;
- López‐Guillermo, A.;
- Martínez‐López, J.;
- Novak, U.;
- Ribrag, V.;
- Roddie, C.;
- Waller, E. K.;
- Feldman, T.;
- Rosenthal, A. C.;
- Sauter, C.;
- von Bonin, M.;
- Karmali, R.;
- Montheard, S.;
- Previtali, A.;
- Abramson, J.
Publication type:
Article
VERY LONG‐TERM FOLLOW‐UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 151, doi. 10.1002/hon.3163_100
By:
- Sarkozy, C.;
- Thieblemont, C.;
- Oberic, L.;
- Moreau, A.;
- Bouabdallah, K.;
- Damaj, G.;
- Gastine, T.;
- Ribrag, V.;
- Casasnovas, O.;
- Haioun, C.;
- Houot, R.;
- Jardin, F.;
- Van Den Neste, E.;
- Cheminant, M.;
- Morschhauser, F.;
- Callana, M.;
- Ghesquieres, H.;
- Gressin, R.;
- Hermine, O.;
- Le Gouill, S.
Publication type:
Article
LONG‐TERM OUTCOMES OF ELDERLY PATIENTS TREATED WITH FRONTLINE R‐CHOP: UPDATE OF THE LNH03‐6B TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.96_2880
By:
- Camus, V.;
- Belot, Aurél.;
- Oberic, L.;
- Sibon, D.;
- Ghesquières, H.;
- Thieblemont, C.;
- Fruchart, C.;
- Casasnovas, O.;
- Michot, Jean‐M.;
- Molina, T. J.;
- Bosly, A.;
- Joubert, Clém.;
- Haioun, C.;
- Delarue, R.;
- Tilly, H.
Publication type:
Article
EARLY POSITRON EMISSION TOMOGRAPHY RESPONSE‐ADAPTED TREATMENT IN LOCALIZED DIFFUSE LARGE B‐CELL LYMPHOMA (AAIPI=0) : RESULTS OF THE PHASE 3 LYSA LNH 09‐1B TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.5_2879
By:
- Bologna, S;
- Vander Borght, T;
- Briere, J;
- Ribrag, V;
- Damaj, G. L;
- Thieblemont, C;
- Feugier, P;
- Peyrade, F;
- Lebras, L;
- Coso, D;
- Sibon, D;
- Bonnet, C;
- Morschhauser, F;
- Ghesquieres, H;
- Becker, S;
- Olivier, P;
- Fabiani, B;
- Tilly, H;
- Haioun, C;
- Bastie, J. N
Publication type:
Article
OUTCOMES IN LATER‐LINES OF THERAPY FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: RESULTS FROM THE INTERNATIONAL SCHOLAR‐5 STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.26_2880
By:
- Ghione, P.;
- Ghesquieres, H.;
- Bobillo, S.;
- Patel, A. R.;
- Kanters, S.;
- Deighton, K.;
- Dong, H.;
- Yang, Y.;
- Ma, L.;
- Limbrick‐Oldfield, E. H.;
- Thornton Snider, J.;
- Wade, S. W.;
- Riberio, M. T.;
- Sudhindra, A.;
- Radford, J.;
- Palomba, M. L.;
- Gribben, J.
Publication type:
Article
BRENTUXIMAB VEDOTIN AS CONSOLIDATION TREATMENT IN PATIENTS WITH STAGE I/II CLASSICAL HODGKIN'S LYMPHOMA AND A POSITIVE FDG‐PET AFTER 2 CYCLES OF ABVD: A LYSA PHASE 2 STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.111_2880
By:
- Gastinne, T.;
- Bouabdallah, K.;
- Moatti, H.;
- Tessoulin, B.;
- Shiano del colella, J. M.;
- Lamy, T.;
- Casasnovas, O.;
- Borel, C.;
- Stamatoullas, A.;
- Gac, A. C.;
- Chaoui, D.;
- Feugier, P.;
- Delmer, A.;
- Bonnet, C.;
- Fornecker, Luc‐M.;
- Lazarovici, J.;
- Le Bras, F.;
- Ghesquieres, H.;
- Meignan, M.;
- Traverse Glehen, A.
Publication type:
Article
PD‐1 BLOCKADE IN A FRENCH SERIES OF 13 RELAPSED / REFRACTORY NK/T‐CELL LYMPHOMA PATIENTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 272, doi. 10.1002/hon.83_2630
By:
- Couronné, L.;
- Chaubard, S.;
- Bruneau, J.;
- Laurent, C.;
- Rossignol, J.;
- Suarez, F.;
- Moignet Autrel, A.;
- Clavert, A.;
- Duléry, R.;
- Alexis, M.;
- Lemonnier, F.;
- Noël, R.;
- Tardy, S.;
- Gaulard, P.;
- Fataccioli, V.;
- Kataoka, K.;
- Ghesquières, H.;
- Salles, G.;
- Bachy, E.;
- Hermine, O.
Publication type:
Article
COMPARISON OF CLINICAL SCORING SYSTEMS IN AGGRESSIVE B‐CELL LYMPHOMAS (BCL): AN INDIVIDUAL PATIENT‐LEVEL ANALYSIS ACROSS INTERNATIONAL TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 248, doi. 10.1002/hon.57_2630
By:
- Schmitz, N.F.;
- Dixon, J.G.;
- Salles, G.;
- Wall, A.;
- Cunningham, D.;
- Poeschel, V.;
- Haioun, C.;
- Tilly, H.;
- Ghesquieres, H.;
- Ziepert, M.;
- Flament, J.;
- Flowers, C.;
- Shi, Q.;
- Ruppert, A.S.
Publication type:
Article
ONE‐YEAR REAL‐LIFE TARGETED NEXT GENERATION SEQUENCING FOR LYMPHOMA DIAGNOSIS: STUDY OF PATIENTS FROM THE FRENCH LYMPHOMA NETWORK IN RHÔNE‐ALPES.
Published in:
Hematological Oncology, 2019, v. 37, p. 186, doi. 10.1002/hon.2630
By:
- Bommier, C.;
- Mauduit, C.;
- Fontaine, J.;
- Bourbon, E.;
- Sujobert, P.;
- Huet, S.;
- Baseggio, L.;
- Hayette, S.;
- Laurent, C.;
- Bachy, E.;
- Ghesquières, H.;
- Salles, G.;
- Traverse‐Glehen, A.
Publication type:
Article
POOLED RESULTS OF THREE ANNUAL COHORTS FROM AN OBSERVATIONAL PROSPECTIVE STUDY DESCRIBING BRENTUXIMAB VEDOTIN USE IN ROUTINE PRACTICE IN FRANCE FOR HODGKIN LYMPHOMA: INTERIM ANALYSIS.
Published in:
Hematological Oncology, 2019, v. 37, p. 492, doi. 10.1002/hon.170_2631
By:
- Sibon, D.;
- Quittet, P.;
- Borel, C.;
- Stamatoullas, A.;
- Franchi‐Rezgui, P.;
- Ghesquieres, H.;
- Dulery, R.;
- Benbrahim, O.;
- Hammoud, M.;
- Durot, E.;
- De Guibert, S.;
- Coulibaly, C.;
- Casasnovas, O.;
- Bouabdallah, R.;
- Brice, P.
Publication type:
Article
PD‐1 BLOCKADE IN A FRENCH SERIES OF 13 RELAPSED / REFRACTORY NK/T‐CELL LYMPHOMA PATIENTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 272, doi. 10.1002/hon.83_2630
By:
- Couronné, L.;
- Chaubard, S.;
- Bruneau, J.;
- Laurent, C.;
- Rossignol, J.;
- Suarez, F.;
- Moignet Autrel, A.;
- Clavert, A.;
- Duléry, R.;
- Alexis, M.;
- Lemonnier, F.;
- Noël, R.;
- Tardy, S.;
- Gaulard, P.;
- Fataccioli, V.;
- Kataoka, K.;
- Ghesquières, H.;
- Salles, G.;
- Bachy, E.;
- Hermine, O.
Publication type:
Article
COMPARISON OF CLINICAL SCORING SYSTEMS IN AGGRESSIVE B‐CELL LYMPHOMAS (BCL): AN INDIVIDUAL PATIENT‐LEVEL ANALYSIS ACROSS INTERNATIONAL TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 248, doi. 10.1002/hon.57_2630
By:
- Schmitz, N.F.;
- Dixon, J.G.;
- Salles, G.;
- Wall, A.;
- Cunningham, D.;
- Poeschel, V.;
- Haioun, C.;
- Tilly, H.;
- Ghesquieres, H.;
- Ziepert, M.;
- Flament, J.;
- Flowers, C.;
- Shi, Q.;
- Ruppert, A.S.
Publication type:
Article
ONE‐YEAR REAL‐LIFE TARGETED NEXT GENERATION SEQUENCING FOR LYMPHOMA DIAGNOSIS: STUDY OF PATIENTS FROM THE FRENCH LYMPHOMA NETWORK IN RHÔNE‐ALPES.
Published in:
Hematological Oncology, 2019, v. 37, p. 186, doi. 10.1002/hon.2630
By:
- Bommier, C.;
- Mauduit, C.;
- Fontaine, J.;
- Bourbon, E.;
- Sujobert, P.;
- Huet, S.;
- Baseggio, L.;
- Hayette, S.;
- Laurent, C.;
- Bachy, E.;
- Ghesquières, H.;
- Salles, G.;
- Traverse‐Glehen, A.
Publication type:
Article
POOLED RESULTS OF THREE ANNUAL COHORTS FROM AN OBSERVATIONAL PROSPECTIVE STUDY DESCRIBING BRENTUXIMAB VEDOTIN USE IN ROUTINE PRACTICE IN FRANCE FOR HODGKIN LYMPHOMA: INTERIM ANALYSIS.
Published in:
Hematological Oncology, 2019, v. 37, p. 492, doi. 10.1002/hon.170_2631
By:
- Sibon, D.;
- Quittet, P.;
- Borel, C.;
- Stamatoullas, A.;
- Franchi‐Rezgui, P.;
- Ghesquieres, H.;
- Dulery, R.;
- Benbrahim, O.;
- Hammoud, M.;
- Durot, E.;
- De Guibert, S.;
- Coulibaly, C.;
- Casasnovas, O.;
- Bouabdallah, R.;
- Brice, P.
Publication type:
Article
THE 5-YEAR FOLLOW-UP RESULTS OF THE C5R PROTOCOL WITH RITUXIMAB AND INTRATHECAL LIPOSOMAL CYTARABINE FOR PRIMARY CNS LYMPHOMA: A PROSPECTIVE PHASE 2 STUDY OF THE LYSA.
Published in:
Hematological Oncology, 2017, v. 35, p. 198, doi. 10.1002/hon.2438_61
By:
- Ghesquieres, H.;
- Tilly, H.;
- Sonet, A.;
- Dupuis, J.;
- Nicolas ‐ Virelizier, E.;
- Andre, M.;
- Trullemans, F.;
- Eisenmann, J.;
- Delarue, R.;
- Fleck, E.;
- Morschhauser, F.;
- Blay, J.
Publication type:
Article
TUMOR GENOMIC COPY NUMBER ABNORMALITIES ANALYZED BY HIGH RESOLUTION SNP ARRAY IMPACT OUTCOME OF PRIMARY CNS LYMPHOMA: A RETROSPECTIVE ANALYSIS ON 68 PATIENTS.
Published in:
Hematological Oncology, 2017, v. 35, p. 160, doi. 10.1002/hon.2438_16
By:
- Ghesquieres, H.;
- Tesson, B.;
- Courtois ‐ Cox, S.;
- Boyault, S.;
- Nicolas ‐ Virelizier, E.;
- Carrere, M.;
- Traverse ‐ Glehen, A.;
- Perrin, C.;
- Chassagne ‐ Clement, C.;
- Jouanneau, E.;
- Salles, G.;
- Honnorat, J.;
- Blay, J.;
- Meyronet, D.
Publication type:
Article
NON-MEDIASTINAL CASES OF GREY ZONE LYMPHOMA: A PATHOLOGICAL AND CLINICAL SERIES OF 17 CASES FROM THE LYSA.
Published in:
Hematological Oncology, 2017, v. 35, p. 41, doi. 10.1002/hon.2437_22
By:
- Sarkozy, C.;
- Mottok, A.;
- Ghesquieres, H.;
- Herbeaux, C.;
- Ben ‐ Neriah, S.;
- Chassagne ‐ Clément, C.;
- Copie ‐ Bergmann, C.;
- Picquenot, J.;
- Cornillon, J.;
- Lemal, R.;
- Bonnet, A.;
- Manson, G.;
- Golfier, C.;
- Michallet, A.;
- Salles, G.;
- Steidl, C.;
- Traverse ‐ Glehen, A.
Publication type:
Article
CHARACTERISTICS AND OUTCOMES OF RELAPSED FOLLICULAR LYMPHOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN THE RITUXIMAB ERA.
Published in:
Hematological Oncology, 2017, v. 35, p. 220, doi. 10.1002/hon.2438_84
By:
- Sesques, P.;
- Golfier, C.;
- Boursier, J.;
- Bachy, E.;
- Traverse ‐ Glehen, A.;
- Le Gouill, S.;
- Casasnovas, O.;
- Ghesquieres, H.;
- Salles, G.
Publication type:
Article
CAUSE OF DEATH IN FOLLICULAR LYMPHOMA IN THE RITUXIMAB ERA: A POOLED ANALYSIS OF FRENCH AND US COHORTS.
Published in:
Hematological Oncology, 2017, v. 35, p. 34, doi. 10.1002/hon.2437_15
By:
- Sarkozy, C.;
- Link, B.;
- Ghesquieres, H.;
- Maurer, M.;
- Nicolas ‐ Virelizier, E.;
- Thompson, C.;
- Traverse ‐ Glehen, A.;
- Feldman, A.;
- Allmer, C.;
- Slager, S.;
- Ansell, S.;
- Habermann, T.;
- Bachy, E.;
- Cerhan, J.;
- Salles, G.
Publication type:
Article
PHASE I/II STUDY OF BRENTUXIMAB VEDOTIN IN REFRACTORY/RELAPSED HODGKIN LYMPHOMA PATIENTS TREATED BY CHEMOTHERAPY (ICE) IN SECOND LINE BEFORE AUTOLOGOUS TRANSPLANTATION.
Published in:
Hematological Oncology, 2017, v. 35, p. 423, doi. 10.1002/hon.2440_6
By:
- Stamatoullas, A.;
- Ghesquières, H.;
- Quittet, P.;
- Morschhauser, F.;
- Ribrag, V.;
- Brice, P.
Publication type:
Article
Combination of rituximab with chemotherapy in diffuse large ß-cell lymphoma. Evaluation in daily practice before and after approval of rituximab in this indication.
Published in:
2008
By:
- Ghesquières H;
- Ferlay C;
- Sebban C;
- Chassagne C;
- Carausu L;
- Gargi T;
- Favier B;
- Philip I;
- Blay J;
- Biron P
Publication type:
Journal Article
Correction to: Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma.
Published in:
2021
By:
- Manson, G.;
- Brice, P.;
- Herbaux, C.;
- Silva, M. G.;
- Bouabdallah, K.;
- Deau, B.;
- Bouteloup, J.;
- Schiano, J. M.;
- Nicolas-Virelizier, E.;
- Maerevoet, M.;
- Ghesquieres, H.;
- Stamatoullas, A.;
- Antier, C.;
- Carlo-Stella, C.;
- de Charette, M.;
- Poizeau, F.;
- Dercle, L.;
- Houot, Roch
Publication type:
Correction Notice
Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 4, p. 1144, doi. 10.1007/s00259-020-05015-2
By:
- Manson, G.;
- Brice, P.;
- Herbaux, C.;
- Silva, M. G.;
- Bouabdallah, K.;
- Deau, B.;
- Bouteloup, J.;
- Schiano, J. M.;
- Nicolas-Virelizier, E.;
- Maerevoet, M.;
- Ghesquieres, H.;
- Stamatoullas, A.;
- Antier, C.;
- Carlo-Stella, C.;
- de Charette, M.;
- Poizeau, F.;
- Dercle, L.;
- Houot, Roch
Publication type:
Article

Found: 38